{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:05:51Z","timestamp":1761577551311,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MIS 348157"],"award-info":[{"award-number":["MIS 348157"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.meegid.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:28:52Z","timestamp":1512523732000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-4211","authenticated-orcid":false,"given":"S.","family":"Tsiomita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2784-3695","authenticated-orcid":false,"given":"U.","family":"Georgopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.P.","family":"Doumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Koskinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Adamidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Papaloukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Thyphronitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.meegid.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.meegid.2017.12.002_bb0010","first-page":"251","article-title":"Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis","volume":"21","author":"Costantini","year":"2010","journal-title":"Eur. Cytokine Netw."},{"issue":"6","key":"10.1016\/j.meegid.2017.12.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.meegid.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.meegid.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/biostatistics\/4.4.523","article-title":"Combining biomarkers to detect disease with application to prostate cancer","volume":"4","author":"Etzioni","year":"2003","journal-title":"Biostatistics"},{"issue":"31","key":"10.1016\/j.meegid.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.3748\/wjg.v20.i31.10851","article-title":"Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future","volume":"20","author":"Fitzpatrick","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/liv.12984","article-title":"The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients","volume":"36","author":"Funakoshi","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12032-013-0808-0","article-title":"HE4 combined with CA125: favorable screening tool for ovarian cancer","volume":"31","author":"Ghasemi","year":"2013","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1145\/1656274.1656278","article-title":"The WEKA data mining software","volume":"11","author":"Hall","year":"2009","journal-title":"SIGKDD Explor. Newsl."},{"issue":"11","key":"10.1016\/j.meegid.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"e6132","DOI":"10.5812\/hepatmon.6132","article-title":"The role of fas\/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma","volume":"12","author":"Hammam","year":"2012","journal-title":"Hepat. Mon."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3748\/wjg.v16.i5.625","article-title":"Serum thymosin \u03b24 levels in patients with hepatitis B virus-related liver failure","volume":"16","author":"Han","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.meegid.2017.12.002_bb0060","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1582-4934.2010.01204.x","article-title":"From proteomic multimarker profiling to interesting proteins: thymosin-\u03b2 4 and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions","volume":"15","author":"Henkel","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.meegid.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/sim.5542","article-title":"Linear combinations of biomarkers to improve diagnostic accuracy with three ordinal diagnostic categories","volume":"32","author":"Kang","year":"2013","journal-title":"Stat. Med."},{"key":"10.1016\/j.meegid.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2047-783X-17-9","article-title":"Cytokine\/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C","volume":"17","author":"Katsounas","year":"2012","journal-title":"Eur. J. Med. Res."},{"issue":"14","key":"10.1016\/j.meegid.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.4254\/wjh.v7.i14.1843","article-title":"Hepatitis C cirrhosis: new perspectives for diagnosis and treatment","volume":"7","author":"Khullar","year":"2015","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.3390\/ijms160510624","article-title":"Potential role of thymosin beta 4 in liver fibrosis","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.meegid.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3748\/wjg.v10.i24.3650","article-title":"Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients","volume":"10","author":"Lapinski","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.meegid.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3892\/or.2012.1832","article-title":"Emerging biomarkers of prostate cancer (review)","volume":"28","author":"Martin","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.meegid.2017.12.002_bb0095","series-title":"Journal of Hepatology","article-title":"Natural history and predictors of disease severity in chronic hepatitis C","volume":"vol. 44","author":"Massard","year":"2006"},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/S1413-86702009000500013","article-title":"Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C","volume":"13","author":"Moura","year":"2009","journal-title":"Braz. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/147323000303100505","article-title":"Elevated serum soluble Fas levels in the various stages of hepatitis C virus-induced liver disease","volume":"31","author":"\u00d6zaslan","year":"2003","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"year":"1993","series-title":"C4.5: Programs for Machine Learning","author":"Quinlan","key":"10.1016\/j.meegid.2017.12.002_bb0120"},{"issue":"3","key":"10.1016\/j.meegid.2017.12.002_bb0125","first-page":"e15","article-title":"T-cell responses in hepatitis B and C virus infection: similarities and differences","volume":"2","author":"Schmidt","year":"2013","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1109\/JBHI.2014.2344732","article-title":"Analysis of protein interaction networks for the detection of candidate hepatitis B and C biomarkers","volume":"19","author":"Simos","year":"2015","journal-title":"IEEE J. Biomed. Health Inform."},{"issue":"6","key":"10.1016\/j.meegid.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"4","key":"10.1016\/j.meegid.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"e0175482","DOI":"10.1371\/journal.pone.0175482","article-title":"No contribution of lifestyle and environmental exposures to gender discrepancy of liver disease severity in chronic hepatitis B infection: observations from the Haimen City cohort","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.meegid.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"35403","DOI":"10.18632\/oncotarget.15893","article-title":"Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0053519","article-title":"Serum apoptosis markers related to liver damage in chronic hepatitis C: SFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children","volume":"8","author":"Valva","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.meegid.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3748\/wjg.v9.i12.2671","article-title":"Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas\/FasL system","volume":"9","author":"Wang","year":"2003","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.meegid.2017.12.002_bb0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/ar2839","article-title":"Biomarkers: in combination they may do better","volume":"11","author":"Williams","year":"2009","journal-title":"Arthritis Res. Ther."},{"year":"2016","series-title":"Data Mining: Practical Machine Learning Tools and Techniques","author":"Witten","key":"10.1016\/j.meegid.2017.12.002_bb0170"},{"issue":"1","key":"10.1016\/j.meegid.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12874-015-0085-z","article-title":"Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy","volume":"15","author":"Xu","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"issue":"4","key":"10.1016\/j.meegid.2017.12.002_bb0180","first-page":"577","article-title":"Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis","volume":"1","author":"Zhang","year":"2002","journal-title":"Hepatobiliary Pancreat. Dis. Int."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817304197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817304197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:33:58Z","timestamp":1761575638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134817304197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"alternative-id":["S1567134817304197"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2017.12.002","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}